Physical activity, physical capacity and sedentary behavior among asthma patients

Figures & data

Table 1. Division into mild-moderate asthma vs. severe asthma defined by controller medication and the GINA Steps in the GINA 2019 Guidelines [1].

Doses are in microgram. ICS=Inhaled Corticosteroids; GINA= Global Initiative for Asthma; LABA=Long-Acting Beta-Agonists; CFC= Chloroflurocarbon propellant; HFA= Hydrofluroalkane propellant; DPI=Dry powder inhaler.

Figure 1. Study flow.

Table 2. Demographic characteristics of all participants.

Data on Age, Sex, Sedentary percentage, Steps / day, Diurnal PEF Variability, Eosinophilic count and Immunoglobulin E are only measured or collected once.

BMI=Body Mass Index; FEV1= Forced expired volume in the first second; FVC=Forced vital capacity; PEF= peak expiratory flow; FeNO= fractional exhaled nitric oxide; ACQ= Asthma Control Questionnaire; Mini-AQLQ= Mini Asthma Quality of Life Questionnaire; SNOT-22= Sino-Nasal Outcome Test 22; SF-12=Short Form 12 Health Survey; GINA= The Global Initiative for Asthma

Table 3. Comparison of outcomes between GINA1-3 and GINA4-5 at Week 0 and Week 4 adjusted for age and BMI. There is only one comparison of sedentary percentage, steps per day and diurnal PEF variability as this is an average of 4 weeks (from Week 0 to Week 4).

Values in bold indicates statistical significance at p<0.05. Data on Age, Sex, Sedentary percentage, Steps / day, Diurnal PEF Variability, Eosinophilic count and Immunoglobulin E are only collected once.

BMI=Body Mass Index; FEV1= Forced expired volume in the first second; FVC=Forced vital capacity; PEF= peak expiratory flow; FeNO= fractional exhaled nitric oxide; ACQ= Asthma Control Questionnaire; Mini-AQLQ= Mini Asthma Quality of Life Questionnaire; SNOT-22= Sino-Nasal Outcome Test 22; SF-12=Short Form 12 Health Survey

Table 4. Correlation matrix showing Pearson’s correlation coefficients between outcomes. Lower left half represents correlations between outcomes at week 0. Upper right half (grey shade) represents correlations between outcomes at week 4 that are statistically significant at both week 0 and 4.

Values in bold indicate statistical significance at p < 0.05. Cells with green background have statistically significant positive correlations. Cells with yellow background have statistically significant negative correlations. Cells with white/grey background have statistically non-significant correlations.† Indicates statistically significant correlation with Eosinophilic count at week 0, and Eosinophilic count is measured only at Week 0.⁂ Indicates that the physical activity outcomes are quantified as an average of the 4-week period from Week 0 to Week 4.

Reddel HK, FitzGerald JM, Bateman ED, et al. GINA 2019: a fundamental change in asthma management. Eur Respir J. [Internet]. 2019 Jun 1;53(6):1901046. http://erj.ersjournals.com/content/53/6/1901046.abstract

 PubMed Web of Science ®Google Scholar

Data availability statement

The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.